MR-107A-02: Revolutionizing Non-Opioid Pain Man...

By Rene Pretorius

May 12, 2025

Viatris Inc.
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
ZEVASKYN Gene Therapy: A Breakthrough for Recessive Dystrophic Epidermolysis ...
Nipocalimab for Myasthenia Gravis Treatment
Trodelvy Keytruda Combination Delivers Breakthrough Results in Metastatic Tri...
Urgent Need for Pediatric Heart Devices
FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough i...
Market Leadership in Sight as Eli Lilly’s Oral GLP-1 Medication Orforglipron ...
Neoadjuvant Immunotherapy Efficacy: Enhancing Treatment Strategies for Head a...
Challenges in Accelerating Innovative Paediatric Medicine